269055-15-4
269055-15-4
Chemical Structure
Etravirine
Synonym(s): R165335; TMC125
- CAS No.: 269055-15-4
- Formula:C20H15BrN6O
- Molecular Weight:435.28
IUPAC Name: 4-((6-amino-5-bromo-2-((4-cyanophenyl)amino)pyrimidin-4-yl)oxy)-3,5-dimethylbenzonitrile
InChIKey: PYGWGZALEOIKDF-UHFFFAOYSA-N
SMILES: N#CC1=CC(C)=C(C(C)=C1)OC2=NC(NC3=CC=C(C=C3)C#N)=NC(N)=C2Br
Biological Activity: Etravirine (R165335; TMC125) is a non-nucleoside reverse transcriptase inhibitor (NNRTI) used for the treatment of HIV.
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Etravirine | 99.07% | Etravirine (R165335; TMC125) is a non-nucleoside reverse transcriptase inhibitor (NNRTI) used for the treatment of HIV. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Etravirine (Standard) | ≥98% | Etravirine (Standard) is the analytical standard of Etravirine. This product is intended for research and analytical applications. Etravirine (R165335; TMC125) is a non-nucleoside reverse transcriptase inhibitor (NNRTI) used for the treatment of HIV. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Etravirine-d4 | 98.31% | Etravirine-d4 is the deuterium labeled Etravirine. Etravirine is a non-nucleoside reverse transcriptase inhibitor (NNRTI) used for the treatment of HIV. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Etravirine-d8 | Etravirine-d8 is the deuterium labeled Etravirine. Etravirine (R165335) is a non-nucleoside reverse transcriptase inhibitor (NNRTI) used for the treatment of HIV. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Etravirine-13C3 | Etravirine-13C3 (R165335-13C3) is the 13C-labeled Etravirine (HY-90005). Etravirine (R165335; TMC125) is a non-nucleoside reverse transcriptase inhibitor (NNRTI) used for the treatment of HIV. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
